Guest Column | May 24, 2012

Wanted: A Revolution In CNS Drug Development

By John Harrison, PhD, Scientific Consultant, CRF Health

I managed to find time last November to attend the second CNS Summit Meeting. It seems difficult to find time for these events, but I am always pleased to have the opportunity to attend. The theme for this event was development and innovation in CNS drug development, a topic close to my heart. Plus the Boca Raton Resort & Club is no bad place to hang out. We started with an excellent ‘Call to arms’ from Patrick Kennedy, an inspirational speaker (and if you closed your eyes you could hear the same rich speaking tones of his uncle John). His topic was ‘The Importance of Collaboration and Innovation in Developing New CNS Treatments’. This is just one of the drives for innovation, a keenness to establish collaborative arrangements in a pre-competitive space. The theme is one of sharing, especially of data collected for validation purposes. I’m convinced this is an idea whose time has come. Working in psychiatric and neurological drug development is a considerable  challenge. Luca Santarelli, Sr. Vice President at Roche, has a magnificent slide on which he uses a Dantean  metaphor comparing different therapeutic areas – with CNS development mapping to ‘hell’.

CRF Health, a CRF Bracket Company